Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;114:597-605
doi: 10.1161/CIRCULATIONAHA.106.621854
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldin, A.
Right arrow Articles by Creager, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldin, A.
Right arrow Articles by Creager, M. A.
Related Collections
Right arrow Other diabetes
Right arrow Other Vascular biology
Right arrow Cell signalling/signal transduction

(Circulation. 2006;114:597-605.)
© 2006 American Heart Association, Inc.


Basic Science for Clinicians

Advanced Glycation End Products

Sparking the Development of Diabetic Vascular Injury

Alison Goldin, BA; Joshua A. Beckman, MD; Ann Marie Schmidt, MD; Mark A. Creager, MD

From the Cardiovascular Division (A.G., J.A.B., M.A.C.), Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass, and Columbia University Medical Center (A.M.S.), New York, NY.

Correspondence to Mark A. Creager, MD, Brigham and Women’s Hospital, Cardiovascular Division, 75 Francis St, Boston, MA 02115. E-mail mcreager{at}partners.org

Advanced glycation end products (AGEs) are proteins or lipids that become glycated after exposure to sugars. AGEs are prevalent in the diabetic vasculature and contribute to the development of atherosclerosis. The presence and accumulation of AGEs in many different cell types affect extracellular and intracellular structure and function. AGEs contribute to a variety of microvascular and macrovascular complications through the formation of cross-links between molecules in the basement membrane of the extracellular matrix and by engaging the receptor for advanced glycation end products (RAGE). Activation of RAGE by AGEs causes upregulation of the transcription factor nuclear factor-{kappa}B and its target genes. Soluble AGEs activate monocytes, and AGEs in the basement membrane inhibit monocyte migration. AGE-bound RAGE increases endothelial permeability to macromolecules. AGEs block nitric oxide activity in the endothelium and cause the production of reactive oxygen species. Because of the emerging evidence about the adverse effects of AGEs on the vasculature of patients with diabetes, a number of different therapies to inhibit AGEs are under investigation.


Key Words: advanced glycosylation end products • diabetes mellitus • vasculature




This article has been cited by other articles:


Home page
DiabetesHome page
C. Qiu, M. F. Cotch, S. Sigurdsson, M. Garcia, R. Klein, F. Jonasson, B. E.K. Klein, G. Eiriksdottir, T. B. Harris, M. A. van Buchem, et al.
Retinal and Cerebral Microvascular Signs and Diabetes: The Age, Gene/Environment Susceptibility-Reykjavik Study
Diabetes, June 1, 2008; 57(6): 1645 - 1650.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
E. Linden, W. Cai, J. C. He, C. Xue, Z. Li, J. Winston, H. Vlassara, and J. Uribarri
Endothelial Dysfunction in Patients with Chronic Kidney Disease Results from Advanced Glycation End Products (AGE)-Mediated Inhibition of Endothelial Nitric Oxide Synthase through RAGE Activation
Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 691 - 698.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Spinetti, N. Kraenkel, C. Emanueli, and P. Madeddu
Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies
Cardiovasc Res, May 1, 2008; 78(2): 265 - 273.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
I. K. LUKIC, P. M. HUMPERT, P. P. NAWROTH, and A. BIERHAUS
The RAGE Pathway: Activation and Perpetuation in the Pathogenesis of Diabetic Neuropathy
Ann. N.Y. Acad. Sci., April 1, 2008; 1126(1): 76 - 80.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S.-Y. Goh and M. E. Cooper
The Role of Advanced Glycation End Products in Progression and Complications of Diabetes
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1143 - 1152.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Dietrich, M. Jimenez, E. A. Krall Kaye, P. S. Vokonas, and R. I. Garcia
Age-Dependent Associations Between Chronic Periodontitis/Edentulism and Risk of Coronary Heart Disease
Circulation, April 1, 2008; 117(13): 1668 - 1674.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. Golledge, M. Karan, C. S. Moran, J. Muller, P. Clancy, A. E. Dear, and P. E. Norman
Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactions
Eur. Heart J., March 1, 2008; 29(5): 665 - 672.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
C. Tatone, F. Amicarelli, M. C. Carbone, P. Monteleone, D. Caserta, R. Marci, P. G. Artini, P. Piomboni, and R. Focarelli
Cellular and molecular aspects of ovarian follicle ageing
Hum. Reprod. Update, March 1, 2008; 14(2): 131 - 142.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
D. M. Kilkenny and J. V. Rocheleau
Fibroblast Growth Factor Receptor-1 Signaling in Pancreatic Islet -Cells Is Modulated by the Extracellular Matrix
Mol. Endocrinol., January 1, 2008; 22(1): 196 - 205.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Aragno, R. Mastrocola, G. Alloatti, I. Vercellinatto, P. Bardini, S. Geuna, M. G. Catalano, O. Danni, and G. Boccuzzi
Oxidative Stress Triggers Cardiac Fibrosis in the Heart of Diabetic Rats
Endocrinology, January 1, 2008; 149(1): 380 - 388.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. N. Lavrentyev, A. M. Estes, and K. U. Malik
Mechanism of High Glucose Induced Angiotensin II Production in Rat Vascular Smooth Muscle Cells
Circ. Res., August 31, 2007; 101(5): 455 - 464.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. Muniyappa, M. Montagnani, K. K. Koh, and M. J. Quon
Cardiovascular Actions of Insulin
Endocr. Rev., August 1, 2007; 28(5): 463 - 491.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
N. Cheung, J. J. Wang, R. Klein, D. J. Couper, A. R. Sharrett, and T. Y. Wong
Diabetic Retinopathy and the Risk of Coronary Heart Disease: The Atherosclerosis Risk in Communities Study
Diabetes Care, July 1, 2007; 30(7): 1742 - 1746.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. A. Maile, B. E. Capps, Y. Ling, G. Xi, and D. R. Clemmons
Hyperglycemia Alters the Responsiveness of Smooth Muscle Cells to Insulin-Like Growth Factor-I
Endocrinology, May 1, 2007; 148(5): 2435 - 2443.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
J. Uribarri, W. Cai, M. Peppa, S. Goodman, L. Ferrucci, G. Striker, and H. Vlassara
Circulating Glycotoxins and Dietary Advanced Glycation Endproducts: Two Links to Inflammatory Response, Oxidative Stress, and Aging
J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2007; 62(4): 427 - 433.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
X. SHEN and K. E. BORNFELDT
Mouse Models for Studies of Cardiovascular Complications of Type 1 Diabetes
Ann. N.Y. Acad. Sci., April 1, 2007; 1103(1): 202 - 217.
[Abstract] [Full Text] [PDF]